COMPLETED

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To evaluate the effectiveness, feasibility, acceptability, and appropriateness of an ototoxicity screening protocol among head and neck (H\&N) cancer patients followed in survivorship clinic that received cisplatin-based chemoradiation therapy (CRT).

Official Title

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS) Protocol

Quick Facts

Study Start:2023-06-06
Study Completion:2025-02-25
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05789316

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult (≥ 18 years old)
  2. * H\&N cancer patients will be eligible for inclusion if they have previously undergone cisplatin-based CRT or radiotherapy, including proton therapy, intensity-modulated radiation therapy, and adaptive radiotherapy-surgery with curative intent (i.e., definitive, neoadjuvant, or adjuvant) or definitive surgery with neoadjuvant or adjuvant radiation.
  1. * Patient has been evaluated by an audiologist within the past 12 months
  2. * Use of a hearing aid
  3. * Received a cochlear implant
  4. * Cannot complete simple forms in English

Contacts and Locations

Principal Investigator

David Lee, M.D.
PRINCIPAL_INVESTIGATOR
Washington University School of Medicine

Study Locations (Sites)

Washington University School of Medicine
St Louis, Missouri, 63110
United States

Collaborators and Investigators

Sponsor: Washington University School of Medicine

  • David Lee, M.D., PRINCIPAL_INVESTIGATOR, Washington University School of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-06
Study Completion Date2025-02-25

Study Record Updates

Study Start Date2023-06-06
Study Completion Date2025-02-25

Terms related to this study

Keywords Provided by Researchers

  • survivorship
  • quality of life
  • cisplatin
  • radiation
  • head and neck cancer
  • hearing loss
  • ototoxicity

Additional Relevant MeSH Terms

  • Head and Neck Cancer Survivors
  • Cancer of the Head and Neck Surviors